Search Results

Did you register for our next Dr. GPCR Virtual Cafe? Register today! Addgene's Dr. research or you want to share your materials, this is the place to go. https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe

Join us for the first virtual cafe talk to hear about the amazing work that Dr. Brian Arey is doing. https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #gpcr #drgpcr #virtualcafe

September 2022 "Morphine, the most widely used analgesic, relieves severe pain by activating the μ-opioid receptor (MOR), whereas naloxone, with only slight structural changes compared to morphine, exhibits inhibitory effect, and is used to treat opioid abuse. The mechanism by which the MOR distinguishes between the two is unclear. Molecular dynamics (MD) simulations on a 1-μs time scale and metadynamics-enhanced conformational sampling are used here to determine the different interactions of these two ligands with MOR: morphine adjusted its pose by continuously flipping deeper into the pocket, whereas naloxone failed to penetrate deeper because its allyl group conflicts with several residues of MOR. The endogenous peptide ligand endomorphin-1 (EM-1) underwent almost no significant conformational changes during the MD simulations. To validate these processes, we employed GIRK4S143T, a MOR-activated Gβγ-protein effector, in combination with mutagenesis and electrophysiological recordings. We verified the role of some key residues in the dynamic recognition of naloxone and morphine and identified the key residue I322, which leads to differential recognition of morphine and naloxone while assisting EM-1 in activating MOR. Reducing the side chain size of I322 (MORI322A) transformed naloxone from an inhibitor directly into an agonist of MOR, and I322A also significantly attenuated the potency of MOR on EM-1, confirming that binding deep in the pocket is critical for the agonistic effect of MOR. This finding reveals a dynamic mechanism for the response of MOR to different ligands and provides a basis for the discovery of new ligands for MOR at the atomic level." Read more at the source #DrGPCR #GPCR #IndustryNews

regarding the role of C3aR in controlling bacterial infections and analyze these results in the context of both

Shoichet, Bryan Roth, et al. for their research on AlphaFold2 structures guide prospective ligand discovery Dr. Stay tuned for further details, as we plan to open registrations for both courses in July 2024. Dr. Episode 152 with Dr. Our most recent episode features our very own Dr. GPCR Board. Tune in and enjoy! Dr.

Katharina Grotsch, Bryan L Roth, Valery V Fokin  et al. for their research on Virtual Screening of a Join our upcoming Dr. GPCR University hands-on workshop with Dr.  The workshop includes: Four x 2-hour Zoom sessions One-on-one meeting with Dr. Hoare Access to Dr. Check our conversation with Dr. Sam Hoare about this hands-on workshop HERE ⬇⬇⬇ Dr. Dr.

This week's highlight: Drs. Brian Krumm and Bryan Roth studied CryoEM structures of adhesion in GPCR CD97, filling gaps. Last Friday was our final Dr. GPCR Symposium for the year, focusing on GPCRs in Immunology and Oncology, concluding the Dr. Sign up for Dr. GPCR Newsletter and stay ahead of the curve with news on the Dr.

This week's highlight: Dr. Bryan L Roth study on Illuminating the understudied GPCR-ome Save the dates: February 8 - 29: Dr. GPCR University live Zoom sessions hosted by Dr. Terry Kenakin. Registrations open on December 15th and close on February 1st to both Dr. Kenakin and Dr. GPCR.

K Shoichet ,  Esther Martinborough ,  Jonathan F Fay ,  Can Cao ,   Bryan L Roth , et al. Dr. GPCR Kicked Off as a Podcast... go for a Premium Membership , you'll not only back our mission but also snag fantastic perks like: Dr Direct line to the Dr. Jude Children's Research Hospital Welcomes Dr.

into designing small molecule drugs, using state-of-the-art examples such as PROTACs. -            Dr Wednesday was a key day for Maria, as she got to participate in a panel discussion alongside Dr. Brian K. Shoichet, Dr. Luc Van Hijfte and Dr. Wendy Young. session was more industry focused than those before, and Maria shared the floor with researchers such as Dr Amanda Dombrowski from Abbvie, Dr. Charles Yeung from Merck and Dr.

October 2022 Use of CRISPR/Cas9-edited HEK293 cells reveals that both conventional and novel protein PKC and mutation of rat mGlu5a Ser901, a PKC-dependent phosphorylation site in the receptor C-tail, both This indicates that isozymes from both classes are involved, compensate for the absence of the other

Dr. You don't want to miss out on our monthly Dr. GPCR Newsletter for exclusive content, check out our latest video featuring Dr. Kathleen Caron. Therapy Research Structure Therapeutics Receives R&D Achievement of the Year Award for GPCR Research Bryan Roth, Natural Products, and the John Daly Legacy Sosei Heptares’ Partner, Pfizer, Progresses Its GLP

The Corner comes will live monthly AMA sessions with Dr. Kenakin. GPCR Updates Learn Pharmacology That Drives Discovery  – From Dr. Explore Dr. This blog post breaks down Dr. Stay curious,   The Dr. GPCR Team

It's starting to look a lot like Christmas at Dr. GPCR! Structure-guided design of a peripherally restricted chemogenetic system Hye Jin Kang , Brian E Krumm , Adrien Tassou , Bryan L Roth , et al. 🕶 University CheatSheet is here!

Dr. Dr. Dr. Dr. Dr.

Dr. Dr. Dr. Dr. Dr.

fantastic paper on Development of Putative Bivalent Dicovalent Ligands for the Adenosine A1 Receptor Bryan Roth  and Brian Krumm  for their excellent study on Molecular glues as potential GPCR therapeutics Sabrina faculty members who adeptly simplify the intricacies of GPCR pharmacology for practical application in both Developing Nations If you reside and work in a developing country, complete this form for free access to Dr

In this Terry’s Corner lesson, Dr. Join before year-end to secure both. 👉   Join Terry's Corner Before Dec 31st, 2025 🎧 Dr. Hudson 🎧 Catch up on Part 2 with Dr. GPCR Year in Review: Carrying Better Experiments Into 2026 As 2025 closes, the Dr. Beyond access, Premium sustains the nonprofit mission behind Dr.

Plus, check out the latest Dr. GPCR tools and key moves in the biotech world. Dr. Become a Dr. GPCR Ambassador - Share & refer with Dr. GPCR.   Join the Affiliate Program     Your Shortcut to Dr. The Dr. Best wishes, The Dr. GPCR Team

In Episode 168 of the Dr. GPCR Podcast, Dr. And that mindset is precisely what makes their new partnership with Dr. GPCR so powerful. ” — Dr. That’s the mission. ” — Dr. Maria Majellaro Now, as official partners of the Dr. Keyword Cloud:   GPCR data platform , fluorescent ligands , assay development , GPCR research community , Dr

Dr. Maria Majellaro’s story, shared in Episode 168 of the Dr. ” — Dr. Maria Majellaro Maria didn’t always know she’d end up in a startup. ” — Dr. With the new  Dr. . 👉 Explore Celtarys’ tools and partnership with Dr.

That’s why this week at Dr. delays key milestones. 🗣️ “Thank you for bringing this (Principles of Pharmacology I) course with Dr I wish Dr. Ingo Hartung : State-of-the-art design of small molecule drugs, including PROTACs Dr. Get The Full Story ➤ Why Dr. GPCR Premium Membership Gives You an Edge Dr.

Hello Sweet GPCR Enthusiasts, This week at Dr. GPCR: a new podcast episode with Dr. Ben Clements, a tour of our official Dr. Scroll down for the science, the strategy, and the sweet stuff 🍬 Dr. The official Dr. GPCR Store is live! Best wishes, The Dr. GPCR Team

, we’re spotlighting Celtarys Research, our newest partner, featured in a blog and podcast with CSO Dr After 40+ years and 250 publications, Dr. Dr. Explore Terry's Corner From Chemistry Lab to GPCR Partner – New Podcast with Celtarys Dr. Stay curious, The Dr. GPCR Team

As a valued Dr. featuring:   A short, focused video A concise written summary with key takeaways Handpicked references by Dr Your Exclusive Premium Member Benefit:   As a thank you for your continued support of the Dr. GPCR Ecosystem, we're giving Dr. Warmest Regards, The Dr. GPCR Team & Terry’s Desk

GPCR Podcast: Leadership, Impact, and GPCR Signaling with Dr. Dr. Yamina’s open letter reflects on how Dr. I wish Dr. No matter where you are in your GPCR journey, Dr.

When PK is misunderstood early, Dr. derail programs Every therapeutic area—CNS, cardiovascular, GI—faces the same core PK constraints Dr Across therapeutic classes, Dr. efficacy and toxicity Dr. Why Terry’s Corner Terry’s Corner  delivers weekly pharmacology lectures from Dr.

Secure Your Access Now ➤ 🗣️ “Thank you for bringing this (Principles of Pharmacology I) course with Dr I wish Dr. best for the sake of promoting more educational opportunities that are sorely needed in the field” — Dr GPCR University Learner Dr. GPCR Podcast - Surviving Discovery’s Gauntlet Dr. The Dr. GPCR Team Read Full Edition ➤

GPCR Colleagues & Curiosity-Driven Minds, We’re starting with exciting Dr. sharpen your skills with our new on-demand course, Techniques for Effective Lead Optimization with Dr Dr. Catch up on past Dr. Stay curious, The Dr. GPCR Team

This week's highlight: Drs. GPCR University's live Zoom sessions hosted by Dr. Terry Kenakin. Registrations are open to Dr. GPCR Ecosystem Members! GPCR Ecosystem group, where you can find Dr. Kenakin and Dr. GPCR Access to Dr.